Article -> Article Details

Astute Analytica publishes a research report on the Global Digital Therapeutics Market. The analysis report contains in-depth data about demand, growth, opportunities, challenges, and restraints. In addition, it provides a thorough examination of the structure and possibility of global and regional industries. 

The Global Digital Therapeutics Market is estimated to witness a major jump in revenue from US$ 3,744.3 Million in 2021 to US$ 24,143.3 Million by 2030. The market is registering a CAGR of 23.1% over the projection period 2022-2030. 

The global market study includes information from key firms on R&D, new product launches, and product responses from global markets. The analysis includes a graphical presentation and a diagrammatic examination of the global market by region.

Request of this Sample Report Here- https://www.astuteanalytica.com/request-sample/digital-therapeutics-market

People and economies globally rely substantially on the healthcare business. It is one of the fastest-growing industries. There is a correlation between income levels and healthcare spending in different nations, with healthcare spending accounting for more than 10% of most industrialized countries’ GDP.

Impact Analysis of COVID-19

Global COVID-19 cases have climbed above 516 million as of May 2022, and the death toll has exceeded 6.25 million. COVID-19 has disproportionately impacted specific racial and ethnic minority groups, as well as underserved and marginalized communities, highlighting the persistent challenges of health equity and health outcomes.

COVID-19 is causing a great deal of emotional, physical, and professional stress among health care personnel. The changing attitudes and behaviors of consumers, the integration of life sciences and health care, fast-growing digital health technology, new talent, and care delivery models, and clinical innovation advanced by COVID-19.

As sector players and the customers, they serve to adapt to a new world of remote working, virtual doctor visits, and a supply chain plagued by shortages of medical goods, employees, and services, the sector is reforming to become more customer-centric.

The Centers for Medicare and Medicaid Services data calculates that the U.S. national healthcare expenditure reached US$ 4.1 trillion in 2020 and is forecast to surpass US$ 6.2 trillion by 2028. According to the Commonwealth Fund, the U.S. spent nearly 17% of gross domestic product (GDP) on healthcare in 2018. Switzerland was the second-highest-ranking country, spending 12.2%. In addition, New Zealand and Australia dedicate only 9.3%.

Regional Analysis

By Component segment of the Global Digital Therapeutics (DTx) Market is sub-segmented into:

·         Hardware

·         Software 

·         Services

Full Report Here- https://www.astuteanalytica.com/industry-report/digital-therapeutics-market

By Application segment of the Global Digital Therapeutics (DTx) Market is sub-segmented into:

·         Preventive Applications

·         Prediabetes​

·         Obesity​

·         Nutrition​

·         Lifestyle Management​

·         Others​

·         Treatment/Care-related Applications​

·         Diabetes​

·         CNS Disorders​

·         Mental Health Disorder

·         Other CNS Disorders​

·         Chronic Respiratory Disorders​

·         Musculoskeletal Disorders​

·         Cardiovascular Diseases

·         Smoking Cessation​

·         Medication Adherence​

·         Gastrointestinal Disorders​

·         Substance Use & Addiction Management​

·         Rehabilitation & Patient Care​

 By Sales Channel segment of the Global Digital Therapeutics (DTx) Market is sub-segmented into:

·         Business-to-business (B2B)

·         Employer

·         Healthcare Provider

·         Payers

·         Pharmaceutical Companies

·         Others

·         Business-to-consumer (B2C)

·         Patient

·         Caregiver

By Region segment of the Global Digital Therapeutics (DTx) Market is sub-segmented into:

·         North America

·         The U.S.

·         Canada

·         Mexico

·         Europe

·         The UK

·         Germany

·         France

·         Italy

·         Spain

·         Poland

·         Russia

·         Rest of Europe

·         Asia Pacific

·         China

·         India

·         Japan

·         Australia & New Zealand

·         ASEAN

·         Rest of Asia Pacific

·         Middle East & Africa (MEA)

·         UAE

·         Saudi Arabia

·         South Africa

·         Rest of MEA

·         South America

·         Argentina

·         Brazil

·         Rest of South America

Key Players Insights

Livongo Health, Inc., Omada Health, Inc., Proteus Digital Health, Inc., Akili Interactive Labs, Inc., 2Morrow Inc., Click Therapeutics Inc., Happify Health, Kaia Health, Teladoc Health, Inc., Medtronic, Pear Therapeutics, Inc., ResMed and Voluntis among others are some key players in the global digital therapeutics market. 

Access Sample Report Here-